
|Articles|April 1, 2021
Jones Lang LaSalle Releases Emerging Life Sciences Markets Index
Next tier of markets is poised to ascend and offer valuable opportunities to both investors and occupiers.
Advertisement
JLL, a global commercial real estate services company, has released its Emerging Life Sciences Markets Index. The report evaluates metro areas with respect to a wide variety of metrics chosen to best reflect the most critical qualities of life sciences markets on the upswing.
Examining 110 US markets, the index highlights where life sciences jobs are growing the most as well as what markets are accelerating and keeping a full pipeline of talent. The result of this research is a three-pronged model:
- Momentum: measures the size of the life sciences employment base and the industry’s momentum
- Talent: measures educational attainment and demographic tailwinds
- Potential: measures forecasted growth of key market performance indicators such as millennial population, median household income growth, and housing availability
For more information and the full report, click
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Approves Datroway for Patients with Metastatic Triple-Negative Breast Cancer Who Are Not PD-1/PD-L1 Inhibitor Candidates
2
What Kinds of Disruption are GLP-1s Expected to Face
3
Eli Lilly and Novo Nordisk Shift Patients From Compounded Drugs to Lower-Cost Weight-Loss Pills: Report
4
The Evolving Relationship Between FDA and Biotech
5




